Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 26, Issue 5, Pages 729-735Publisher
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2007.14.3222
Keywords
-
Categories
Funding
- Cancer Research UK [7714] Funding Source: researchfish
- Cancer Research UK [7714] Funding Source: Medline
Ask authors/readers for more resources
The 70-gene profile is a new prognostic tool that has the potential to greatly improve risk assessment and treatment decision making for early breast cancer. Its prospective validation is currently ongoing through the MINDACT (Microarray in Node-Negative Disease May Avoid Chemotherapy) trial, a 6,000-patient randomized, multicentric trial. This article reviews the several steps in the development of the profile from its discovery to its clinical validation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
